Amundi Sells 721,326 Shares of Lam Research Corporation $LRCX

Key Points

• Amundi reduced its Lam Research stake by 7.1%, selling 721,326 shares and retaining 9.43 million shares worth approximately $4.08 billion. Institutional investors still own about 84.61% of LRCX.
• Lam Research reported strong quarterly results, with $6.72 billion in revenue—up 30% year over year—and EPS of $1.82, exceeding analyst expectations. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $358.97.
• The company raised its quarterly dividend from $0.26 to $0.33 per share, while insiders sold 77,782 shares worth approximately $26.8 million over the past three months.

Amundi cut its stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 7.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,426,153 shares of the semiconductor company's stock after selling 721,326 shares during the quarter. Lam Research accounts for about 1.0% of Amundi's holdings, making the stock its 16th biggest holding. Amundi owned approximately 0.75% of Lam Research worth $4,084,639,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. World Equity Group Inc. increased its holdings in shares of Lam Research by 0.5% in the 2nd quarter. World Equity Group Inc. now owns 5,576 shares of the semiconductor company's stock worth $2,416,000 after buying an additional 29 shares during the last quarter. Tenzing Financial LLC lifted its holdings in shares of Lam Research by 3.5% during the 2nd quarter. Tenzing Financial LLC now owns 1,018 shares of the semiconductor company's stock worth $441,000 after acquiring an additional 34 shares during the last quarter. Advus Financial Partners LLC lifted its holdings in shares of Lam Research by 1.0% during the 2nd quarter. Advus Financial Partners LLC now owns 3,578 shares of the semiconductor company's stock worth $1,550,000 after acquiring an additional 34 shares during the last quarter. Paragon Private Wealth Management LLC grew its position in Lam Research by 1.3% in the second quarter. Paragon Private Wealth Management LLC now owns 2,719 shares of the semiconductor company's stock worth $1,178,000 after acquiring an additional 35 shares in the last quarter. Finally, Gibraltar Capital Management Inc. grew its position in Lam Research by 3.6% in the second quarter. Gibraltar Capital Management Inc. now owns 1,050 shares of the semiconductor company's stock worth $455,000 after acquiring an additional 36 shares in the last quarter. 84.61% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Abhijit Talwalkar sold 18,282 shares of the company's stock in a transaction on Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the sale, the director directly owned 87,142 shares in the company, valued at $29,192,570. This represents a 17.34% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the sale, the director directly owned 199,205 shares of the company's stock, valued at $69,881,114. The trade was a 21.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 77,782 shares of company stock valued at $26,755,370 over the last three months. 0.31% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. B. Riley Financial lowered their price target on Lam Research from $385.00 to $350.00 and set a "buy" rating on the stock in a research report on Thursday, July 30th. Stifel Nicolaus upped their price objective on Lam Research from $325.00 to $425.00 and gave the stock a "buy" rating in a report on Friday, July 10th. Needham & Company LLC reiterated a "buy" rating and set a $390.00 price objective on shares of Lam Research in a research report on Thursday, July 30th. Sanford C. Bernstein raised their price objective on Lam Research from $325.00 to $340.00 and gave the company an "outperform" rating in a report on Thursday, May 21st. Finally, Jefferies Financial Group set a $335.00 price objective on Lam Research and gave the company a "buy" rating in a report on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $358.97.

Lam Research Stock Performance

Shares of LRCX stock opened at $307.65 on Monday. The business has a 50-day moving average of $321.34 and a 200 day moving average of $291.79. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. Lam Research Corporation has a 1-year low of $100.68 and a 1-year high of $438.50. The stock has a market capitalization of $384.97 billion, a PE ratio of 53.41, a P/E/G ratio of 1.22 and a beta of 1.85.

Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, topping analysts' consensus estimates of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The business had revenue of $6.72 billion for the quarter, compared to analysts' expectations of $6.66 billion. During the same period in the previous year, the firm earned $1.33 EPS. The business's quarterly revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, sell-side analysts anticipate that Lam Research Corporation will post 9.33 earnings per share for the current year.

Lam Research Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 14th. Investors of record on Wednesday, September 23rd will be paid a $0.33 dividend. The ex-dividend date of this dividend is Wednesday, September 23rd. This is a positive change from Lam Research's previous quarterly dividend of $0.26. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. Lam Research's payout ratio is presently 18.06%.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam Research’s record June-quarter results and outlook remain key catalysts. Revenue reached $6.72 billion, up 30% year over year, while adjusted earnings exceeded analysts’ expectations. Management guided for approximately $8.10 billion in September-quarter revenue, reinforcing confidence in continued AI- and advanced-chip-related demand. Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates
• Positive Sentiment: The company broke ground on a new Oregon research laboratory and plans to invest more than $3 billion in its global lab network over five years. The investment is intended to support semiconductor research tied to artificial intelligence and next-generation chip production. Lam Research Oregon laboratory announcement
• Positive Sentiment: Lam Research raised its quarterly dividend by approximately 27% to $0.33 per share, improving the stock’s shareholder-return profile after its record quarter. Lam Research dividend increase
• Positive Sentiment: Options activity and bullish institutional positioning may be adding to momentum. More than 1,600 institutions reportedly increased their holdings in the latest quarter, while recent analyst targets—including several between $400 and $500—remain above the current trading range. Lam Research options market article
• Neutral Sentiment: The dividend increase has attracted attention as investors seek income and quality amid geopolitical and inflation concerns, although broader market volatility could continue to affect semiconductor stocks. Stocks with dividend hikes article
• Negative Sentiment: Insiders have reported only sales—not purchases—in the past six months, including transactions by CEO Timothy Archer and other executives. That activity may raise concerns about valuation or profit-taking.
• Negative Sentiment: After substantial long-term gains, some commentary argues that LRCX is fully valued, with elevated valuation metrics leaving less room for disappointment-free execution. UBS also recently lowered its price target to $425, despite remaining above the current share price. UBS lowers Lam Research price target

About Lam Research

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.